InvestorsHub Logo
Followers 59
Posts 11462
Boards Moderated 0
Alias Born 07/16/2006

Re: floblu14 post# 15565

Monday, 05/09/2016 6:04:56 PM

Monday, May 09, 2016 6:04:56 PM

Post# of 20689
It seems like the Doc's don't want the switch the Generic Bio's yet so the insurers will have to work harder.

I can't find any reliable numbers but it but I would guess that Sandoz has only been able to pry around 20% of Neupogen's sales away from Amgen after being on the market for 9 months.

I'm not sure how the drugs are priced.

Generic Bio's aren't following the normal generic path. Maybe it'll take multiple entrants to set the pricing correctly.